January 2024 Publications
- The 2023 UN high-level meeting on tuberculosis: renewing hope, momentum, and commitment to end tuberculosis. Millington KA, White RG, Lipman M, McQuaid CF, Hauser J, Wooding V, Potter J, Abubakar I, Wingfield T. Lancet Respir Med. 2024 Jan. doi: 10.1016/S2213-2600(23)00409-5. Epub 2023 Nov 14.
- Enhancement of the immunogenicity of a Mycobacterium tuberculosis fusion protein using ISCOMATRIX and PLUSCOM nano-adjuvants as prophylactic vaccine after nasal administration in mice. Yousefi Avarvand A, Meshkat Z, Khademi F, Aryan E, Sankian M, Tafaghodi M. Iran J Basic Med Sci. 2024. doi: 10.22038/IJBMS.2023.69295.15100.
- Proteome and immunogenicity differences in BCG Pasteur ATCC 35734 and its derivative, the vaccine candidate BCGΔBCG1419c during planktonic growth in 7H9 and Proskauer Beck media. Flores-Valdez MA, Velázquez-Fernández JB, Pedroza-Roldán C, Aceves-Sánchez MJ, Gutiérrez-Ortega A, López-Romero W, Barba-León J, Rodríguez-Campos J. Tuberculosis (Edinb). 2024 Jan. doi: 10.1016/j.tube.2023.102432. Epub 2023 Nov 28.
- Molecular detection of pre-ribosomal RNAs of Mycobacterium bovis bacille Calmette-Guérin and Mycobacterium tuberculosis to enhance pre-clinical tuberculosis drug and vaccine development. Chang M, Venkatasubramanian S, Barrett H, Urdahl KB, Weigel KM, Cangelosi GA, Shah JA, Saha A, Feng L, Adams KN, Sherman DR, Smith N, Seshadri C, Kublin JG, Murphy SC. Diagn Microbiol Infect Dis. 2024 Jan. doi: 10.1016/j.diagmicrobio.2023.116106. Epub 2023 Oct 16.
- Mucosal and systemic antigen-specific antibody responses correlate with protection against active tuberculosis in nonhuman primates. Ishida E, Corrigan DT, Chen T, Liu Y, Kim RS, Song L, Rutledge TM, Magee DM, LaBaer J, Lowary TL, Lin PL, Achkar JM. EBioMedicine. 2024 Jan. doi: 10.1016/j.ebiom.2023.104897. Epub 2023 Dec 13.
- Mucosal recombinant BCG vaccine induces lung-resident memory macrophages and enhances trained immunity via mTORC2/HK1-mediated metabolic rewiring. Peng X, Zhou Y, Zhang B, Liang X, Feng J, Huang Y, Weng S, Xu Y, Su H. J Biol Chem. 2024 Jan. doi: 10.1016/j.jbc.2023.105518. Epub 2023 Nov 30.
- Research progress on immunological properties of ESAT-6 secreted by Mycobacterium tuberculosis and its role in new vaccines. Li Y, Yu H, Yang Y, Yang G. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2024 Jan. [article in Chinese]
- BCG vaccination-induced acquired control of mycobacterial growth differs from growth control preexisting to BCG vaccination. van Meijgaarden KE, Li W, Moorlag SJCFM, Koeken VACM, Koenen HJPM, Joosten LAB, Vyakarnam A, Ahmed A, Rakshit S, Adiga V, Ottenhoff THM, Li Y, Netea MG, Joosten SA. Nat Commun. 2024 Jan 2. doi: 10.1038/s41467-023-44252-5.
- Optimising the vaccine strategy of BCG, ChAdOx1 85A, and MVA85A for tuberculosis control. Wajja A, Nassanga B, Natukunda A, Serubanja J, Tumusiime J, Akurut H, Oduru G, Nassuuna J, Kabagenyi J, Morrison H, Scott H, Powell Doherty R, Marshall JL, Cabrera Puig I, Cose S, Kaleebu P, Webb EL, Satti I, McShane H, Elliott AM; TB042 Study Team. Lancet Infect Dis. 2024 Jan 3. doi: 10.1016/S1473-3099(23)00758-2.
- Systemic neutrophils are triggered by respiratory Bacillus Calmette- Guérin and mediate pulmonary mycobacterial clearance in synergy with the triggering receptor expressed on myeloid cells 1. Li P, Wang R, Dong WQ, Wang GY, Zhang AD, Chen HC, Tan C. Microb Pathog. 2024 Jan 3. doi: 10.1016/j.micpath.2024.106535.
- A multistage Sendai virus vaccine incorporating latency-associated antigens induces protection against acute and latent tuberculosis. Hu Z, Xia J, Wu J, Zhao H, Ji P, Gu L, Gu W, Chen Z, Xu J, Huang X, Ma J, Chen A, Li J, Shu T, Fan XY. Emerg Microbes Infect. 2024. doi: 10.1080/22221751.2023.2300463. Epub 2024 Jan 4.
- Heat-inactivated mycobacteria activate the toll-like receptor 2 and 4 pathways in the zebrafish model of tuberculosis. Ferreras-Colino E, Contreras M, Risalde MA, Sevilla IA, Delgado E, Domínguez L, Gortazar C, de la Fuente J. Vaccine. 2024 Jan 6. doi: 10.1016/j.vaccine.2023.12.085.
- Mycobacterium tuberculosis: immune response, biomarkers, and therapeutic intervention. Zhuang L, Yang L, Li L, Ye Z, Gong W. MedComm (2020). 2024 Jan 6. doi: 10.1002/mco2.419.
- Multi-omics analysis of innate and adaptive responses to BCG vaccination reveals epigenetic cell states that predict trained immunity. Moorlag SJCFM, Folkman L, Ter Horst R, Krausgruber T, Barreca D, Schuster LC, Fife V, Matzaraki V, Li W, Reichl S, Mourits VP, Koeken VACM, de Bree LCJ, Dijkstra H, Lemmers H, van Cranenbroek B, van Rijssen E, Koenen HJPM, Joosten I, Xu CJ, Li Y, Joosten LAB, van Crevel R, Netea MG, Bock C. Immunity. 2024 Jan 9. doi:10.1016/j.immuni.2023.12.005.
- Untranslated Region Sequences and the Efficacy of mRNA Vaccines against Tuberculosis. Reshetnikov V, Terenin I, Shepelkova G, Yeremeev V, Kolmykov S, Nagornykh M, Kolosova E, Sokolova T, Zaborova O, Kukushkin I, Kazakova A, Kunyk D, Kirshina A, Vasileva O, Seregina K, Pateev I, Kolpakov F, Ivanov R. Int J Mol Sci. 2024 Jan 10. doi: 10.3390/ijms25020888.
- Impaired macrophage and memory T-cell responses to Bacillus Calmette-Guerin nonpolar lipid extract. Sarno A, Leite A, Augusto C, Muller I, de Ângelis L, Pimentel L, Queiroz A, Arruda S. Front Immunol. 2024 Jan 11. doi: 10.3389/fimmu.2023.1263352.
- BCG immunization induces CX3CR1hi effector memory T cells to provide cross-protection via IFN-γ-mediated trained immunity. Tran KA, Pernet E, Sadeghi M, Downey J, Chronopoulos J, Lapshina E, Tsai O, Kaufmann E, Ding J, Divangahi M. Nat Immunol. 2024 Jan 15. doi: 10.1038/s41590-023-01739-z. Epub ahead of print
- A novel Mycobacterium Tuberculosis antigen, MTB48 enhances inflammatory response in LPS-induced RAW264.7 macrophage immune cells. Park JY, Kim HD, Abekura F, Cho SH, Kim CH. Mol Immunol. 2024 Jan 17. doi: 10.1016/j.molimm.2023.12.011.
- Mycobacterium tuberculosis Antigen 85B modifies BCG-induced anti-tuberculosis immunity and favors pathogen survival. Piccaro G, Aquino G, Gigantino V, Tirelli V, Sanchez M, Iorio E, Matarese G, Cassone A, Palma C. J Leukoc Biol. 2024 Jan 18. doi: 10.1093/jleuko/qiae014.
- Exposure to Mycobacterium remodels alveolar macrophages and the early innate response to Mycobacterium tuberculosis infection. Mai D, Jahn A, Murray T, Morikubo M, Lim PN, Cervantes MM, Pham LK, Nemeth J, Urdahl K, Diercks AH, Aderem A, Rothchild AC. PLoS Pathog. 2024 Jan 18. doi: 10.1371/journal.ppat.1011871.
- What is next for BCG revaccination to prevent tuberculosis? White RG, Fiore-Gartland AJ, Hanekom WA, Vekemans J, Garcia-Basteiro AL, Churchyard G, Rangaka MX, Frick M, Behr MA, Hill PC, Mave V. Lancet Respir Med. 2024 Jan 22. doi: 10.1016/S2213-2600(24)00009-2. Epub ahead of print.
- Construction and expression of Mycobacterium tuberculosis fusion protein SHR3 and its immunogenicity analysis in combination with various adjuvants. Zhang Z, Xu L, Wang X, Kong L, Shi Z, Zhong Q, Xu Y, Wang J.Tuberculosis (Edinb). 2024 Jan 23. doi: 10.1016/j.tube.2024.102480.
- Effect of glycosylation on the affinity of the MTB protein Ag85B for specific antibodies: towards the design of a dual-acting vaccine against tuberculosis. Bernardini R, Tengattini S, Li Z, Piubelli L, Bavaro T, Modolea AB, Mattei M, Conti P, Marini S, Zhang Y, Pollegioni L, Temporini C, Terreni M. Biol Direct. 2024 Jan 25. doi: 10.1186/s13062-024-00454-5.
- Identification of differentially recognized T cell epitopes in the spectrum of tuberculosis infection. Panda S, Morgan J, Cheng C, Saito M, Gilman RH, Ciobanu N, Crudu V, Catanzaro DG, Catanzaro A, Rodwell T, Perera JSB, Chathuranga T, Gunasena B, DeSilva AD, Peters B, Sette A, Lindestam Arlehamn CS. Nat Commun. 2024 Jan 26;15(1):765. doi: 10.1038/s41467-024-45058-9.